January 2023
Meraque berhasrat jadi pembekal perkhidmatan dron antara 10 terbaik dunia
KUALA LUMPUR, 10 Jan (Bernama) — Pembekal perkhidmatan dron, Meraque Services Sdn Bhd (Meraque) merancang untuk menjadi pembekal perkhidmatan dron ke-10 terbaik di dunia dalam tempoh lima tahun akan datang, menurut Ketua Pegawai Strateginya Rahman Hussin.
Meraque aims to be among 10th best global drone service provider in five years
KUALA LUMPUR, Jan 10 (Bernama) – Meraque Services Sdn Bhd plans to become the world’s 10th-best drone service provider in the next five years, said chief strategy officer Rahman Hussin.
Meraque berhasrat jadi pembekal dron ke 10 terbaik dunia
#BuletinBernama : Pembekal perkhidmatan dron, Meraque Services Sdn Bhd (Meraque) merancang untuk jadi pembekal perkhidmatan dron ke-10 terbaik dunia dalam tempoh lima tahun kehadapan.
Meraque aims to be 10th best global drone service provider in five years
KUALA LUMPUR: Meraque Services Sdn Bhd plans to become the world’s 10th-best drone service provider in the next five years, said chief strategy officer Rahman Hussin.
Meraque sasar jadi pembekal khidmat dron ke-10 terbaik dunia
KUALA LUMPUR: Pembekal perkhidmatan dron, Meraque Services Sdn Bhd (Meraque) merancang untuk menjadi pembekal perkhidmatan dron ke-10 terbaik di dunia dalam tempoh lima tahun akan datang, menurut Ketua Pegawai Strateginya, Rahman Hussin.
Meraque Targets To Be 10th Best Global Drone Service Provider In Five Years
Meraque Services Sdn Bhd plans to become the world’s 10th-best drone service provider in the next five years, said chief strategy officer Rahman Hussin.
MTDC biaya Biogenes untuk pengkomersialan teknologi aptamer
KUALA LUMPUR, 17 Jan (Bernama) — Perbadanan Pembangunan Teknologi Malaysia (MTDC) dan Pembangunan Ekuiti Sdn Bhd (PESB) hari ini memeterai perjanjian dengan Biogenes Technologies Sdn Bhd untuk pengkomersialan teknologi aptamer.
MTDC biaya Biogenes untuk pengkomersialan teknologi aptamer
#BuletinBernama : Perbadanan Pembangunan Teknologi Malaysia (MTDC) dan Pembangunan Ekuiti Sdn Bhd (PESB) pada Selasa memeterai perjanjian dengan Biogenes Technologies Sdn Bhd untuk pengkomersialan teknologi aptamer.
MTDC to fund Biogenes via NTIS Sandbox Fund 3 for aptamer technology commercialisation
KUALA LUMPUR, Jan 17 (Bernama) — The Malaysian Technology Development Corporation (MTDC) and Pembangunan Ekuiti Sdn Bhd (PESB) today inked agreements with Biogenes Technologies Sdn Bhd for the commercialisation of aptamer technology.
MTDC to fund Biogenes via NTIS Sandbox Fund 3 for aptamer technology commercialisation
#BernamaNews: The Malaysian Technology Development Cooperation (MTDC) and Pembangunan Ekuiti Sdn Bhd signed funding agreements with Biogenes Technologies Sdn Bhd via the National Technology Innovation Sandbox (NTIS) Fund 3 to commercialize aptamer technology for healthcare diagnostics.
MTDC terus komited biaya Biogenes komersial teknologi aptamer melalui Dana 3 NTIS
KUALA LUMPUR: Perbadanan Pembangunan Teknologi Malaysia (MTDC) dan Pembangunan Ekuiti Sdn Bhd (PESB) hari ini menandatangani perjanjian bersama Biogenes Technologies Sdn Bhd (Biogenes) bagi pengkomersialan teknologi aptamer.
Malaysian molecular diagnostics, genomics startup Biogenes scores US$5.7M funding
KUALA LUMPUR: Pembekal perkhidmatan dron, Meraque Services Sdn Bhd (Meraque) merancang untuk menjadi pembekal perkhidmatan dron ke-10 terbaik di dunia dalam tempoh lima tahun akan datang, menurut Ketua Pegawai Strateginya, Rahman Hussin.
Malaysian biotech firm banks $5.7m in series A round
Biogenes Technologies develops, produces, and markets synthetic antibody diagnostics products via its proprietary platform. The biotech firm is headquartered in Malaysia and plans to enter Indonesia and the Philippines this year.
This M’sian biotech startup bagged US$6.9M funds from local investors, here’s what it does
Biogenes Technologies Sdn Bhd (Biogenes), a Malaysian biotech startup, has bagged US$5.7 million for its Series A funding from Pembangunan Ekuiti Sdn Bhd (PESB), according to a January 18 press release. The fresh funds from PESB will go towards expanding Biogenes’ proprietary technology platforms across Southeast Asia, namely the Philippines …
Biogenes inks funding agreement with MTDC, PESB
KUALA LUMPUR: Biogenes Technologies Sdn Bhd (Biogenes) is gearing up to hit its next milestone after receiving RM5.5 million in funding.
Pautan
Pautan
ACE Market debutant TT Vision surges over 300% at opening bell
KUALA LUMPUR: The share price of TT Vision Holdings Bhd skyrocketed to RM1.49 a share at the opening bell, representing an over 300% increase from its initial public offering (IPO) price of 34 sen a share.
Pautan
Pautan
TT Vision makes impressive market debut
KUALA LUMPUR: TT Vision Holdings Bhd’s (TTVHB) debut on the ACE Market yesterday saw its shares opening at RM1.49, which represented a 338.24% premium over its issue price of 34 sen per share.
Pautan
Pautan
TT Vision catat premium lebih 300%
KUALA LUMPUR: TT Vision Holdings Bhd (TTVHB) membuat penampilan sulung mantap di Pasaran Ace Bursa Malaysia pagi tadi.
Pautan
Pautan
TT Vision opens with massive 338% premium on ACE Market debut
KUALA LUMPUR: Technology solutions company TT Vision Holdings Bhd made a huge statement on its impressive debut on the ACE Market today following its voluntary delisting on the LEAP Market.
Pautan
Pautan
TT Vision jumps 276% over IPO price on maiden trading day
KUALA LUMPUR (Jan 18): TT Vision Holdings Bhd made an impressive debut on the ACE Market of Bursa Malaysia on Wednesday (Jan 18).
Pautan
Pautan
TT Vision opens at RM1.49 for 338% premium in debut on ACE Market
PETALING JAYA: TT Vision Holdings Bhd (TTVHB) made an eye-catching debut on the ACE Market of Bursa Malaysia Securities today, opening at RM1.49 for a 338.24% premium over its issue price of 34 sen per share on volume of 7.05 million shares.
Pautan
Pautan
Saham TT Vision catat premium luar biasa
KUALA LUMPUR: TT Vision Holdings Bhd (TTVHB) mula disenaraikan di Pasaran ACE Bursa Malaysia dengan kukuh, dibuka pada RM1.49 bagi premium 338.24 peratus daripada harga tawaran awam permulaan (IPO) sebanyak 34 sen sesaham.
Pautan
Pautan
TT Vision bermula cemerlang di Bursa Malaysia dengan premium RM1.15 daripada IPO
KUALA LUMPUR 18 Jan – TT Vision Holdings Berhad bermula cemerlang di Pasaran ACE Bursa Malaysia apabila dibuka pada RM1.49 atau premium RM1.15 atau 33.823% berbanding haraga tawaran awam permulaan (IPO) sebanyak 34 sen.
Pautan
Pautan
Malaysia biotech startup Biogenes raises $5.7m in Series A funding round, to expand in PH
Biogenes Technologies Sdn Bhd (Biogenes), a Malaysian Research and Development (R&D) startup commercializing healthcare diagnostics using aptamers (synthetic antibodies), recently announced securing $5.7m during a Series A funding round from Pembangunan Ekuiti Sdn Bhd (PESB), a Malaysian Venture Capital Management Corporation …
Pautan
Pautan
PESB Awards US$5.7M Grant To Malaysian Biotech Startup
Biogenes Technologies Sdn Bhd (Biogenes), a Malaysian biotech startup, has bagged US$5.7 million for its Series A funding from Pembangunan Ekuiti Sdn Bhd (PESB), according to a January 18 press release.
Pautan
Pautan
Biogenes sasar sayap di rantau Asia dengan teknologi aptamer
KUALA LUMPUR, 24 Jan (Bernama) — Penyedia teknologi penderia Biogenes Technologies Sdn Bhd menyasarkan untuk mempertingkat pengkomersialan teknologi kit ujian menggunakan aptamer yang dibangunkannya, APTSENSE di rantau Asia dalam tempoh 5-10 tahun akan datang.
Pautan
Pautan
Biogenes aims to expand aptamer technology commercialisation in Asian region within 5 to 10 years
KUALA LUMPUR – Perkhidmatan pemantauan dan teleperubatan pesakit secara maya selepas discaj (EM Watch) akan diperluas ke jabatan dan hospital di seluruh negara.
Pautan
Pautan
Biogenes sasar sayap di rantau asia dengan teknologi Aptamer
#BuletinBernama: Penyedia teknologi penderia Biogenes Technologies Sdn Bhd berhasrat untuk mempertingkatkan pengkomersilan teknologi kit ujian menggunakan aptamer yang di bina syarikat itu iaitu APTSENSE di rantau Asia dalam jangkamasa lima hingga ke 10 tahun akan datang.
Pautan
Pautan
